Myomo, Inc.
(NYSE Amex Equities : MYO)

( )
MYO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Distribution Services » Medical Distributors
symbolcompany%chnglast%shortavg$volume
MCKMcKesson Corp. 0.19%322.152.9%$424.47m
ABCAmerisourceBergen Corp. 0.07%148.568.0%$242.44m
CAHCardinal Health, Inc. 0.00%54.452.8%$126.92m
HSICHenry Schein, Inc. 0.00%77.291.7%$59.97m
HLFHerbalife Nutrition Ltd. 0.43%23.1725.2%$40.79m
OMIOwens & Minor, Inc. -0.03%33.3612.5%$23.42m
PDCOPatterson Cos., Inc. 0.00%28.4711.5%$19.94m
YI111, Inc. 0.00%2.180.0%$1.76m
COSMCosmos Holdings, Inc. 0.00%0.440.0%$0.75m
JWELJowell Global Ltd. 0.00%2.970.0%$0.23m
MYOMyomo, Inc. 2.09%1.950.0%$0.19m
MOHOECMOHO Ltd. 0.00%0.190.0%$0.19m

Company Profile

Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. It offers MyoPro, an upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.